Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: cyclodextrin

July 24, 2023 E-ducation / Events / Non-pharma applications / Pharma applications

Workshop on Cyclodextrins, Turin 2023

The Italian Association of Chemistry and Cyclodextrin Technology, with The Department of Chemistry of the University of Turin is organizing

Continue reading

July 6, 2022 Events

V International Summer School on Cyclodextrins

The 4-7 September 2022 in Ascea (Salerno, Italy) is the V International Summer School on Cyclodextrins, which welcomes graduate students,

Continue reading

April 27, 2022 Analysis

Cyclodextrins interfere in the ORAC method to measure antioxidant activity

                Oxygen Radical Absorbance Capacity (ORAC) is a water-based method commonly used to determine the antioxidant capacity of bioactive compounds

Continue reading

February 21, 2022 Drug delivery / Pharma applications

Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug Niclosamide

Direct extrusion of hydroxypropyl beta-cyclodextrin (HP-β-CD)-based powder blends using the most innovative 3D printing technology, Direct Powder Extrusion (DPE), is

Continue reading

December 9, 2021 Non-pharma applications / Pharma applications

Barentz Acquires Gangwal in India

Barentz International, a leading global life science ingredients distributor announced an agreement to acquire a majority stake in the distribution

Continue reading

May 8, 2020 CD as API / CD derivatives / Pharma applications / Uncategorized

UC Berkeley, Excivion and CycloLab develop antiviral cyclodextrins against SARS-CoV-2

UC Berkeley, Excivion and Cyclolab announce a supplemental grant awarded to UC Berkeley by the National Institutes of Health to evaluate a wide

Continue reading

Recent Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (362)
  • CD derivatives (446)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,245)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Obituary for Prof. Dr.-Ing. Wolfram Saenger
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin?
  • Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function
  • Effects of water matrix constituents on micropollutant removal by activated carbon and b-cyclodextrin polymer adsorbents
  • Green Extraction Techniques of Bioactive Compounds: A State-of-the-Art Review
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...